Acceptance and Commitment Therapy for Mesh Injury: A HSCED Series
The Mesh Scandal: Acceptance and Commitment Therapy for Psychological Distress in Mesh Injured Women. A Hermeneutic Single-Case Efficacy Design Series.
The Patient Safety Commissioner estimates that at least 10,000 women in England have experienced significant harm resulting from vaginal mesh implants. Adverse effects resulting in psychological distress and reduced quality of life have been reported. The purpose of the study is to explore the efficacy of Acceptance and Commitment Therapy (ACT) for women with mesh injury experiencing psychological distress.
The study will use a Hermeneutic Single-Case Efficacy Design to answer the primary and secondary objectives.
Primary objective: To investigate whether ACT is an effective therapeutic intervention for women experiencing psychological distress due to mesh injury.
Secondary objectives: To determine whether there are any meaningful changes throughout the ACT intervention; whether these changes can be attributed to the ACT intervention and what factors contribute to the changes.
Participants will undergo a ten-session ACT intervention and follow-up session. A qualitative interview will be carried out to explore the change experience.
調査の概要
状態
詳細な説明
NICE guidelines recognise the physical and psychological impact of mesh complications and recommends that psychological and psychosexual support is offered to women affected. Despite this, a therapeutic intervention for mesh complications has not yet been explored. Acceptance and Commitment Therapy (ACT) as been empirically supported for its use with populations with long term health conditions.
The study will use a hermeneutic single-case efficacy design and evaluate the process of change during the intervention. Following the ACT intervention, rich case records for each participant will be created using quantitative and qualitative data; this data will consist of demographic data, outcome measures and therapy material. The rich case records will be cross-referenced and amalgamated into an "affirmative" brief that presents evidence that the change can be attributed to the therapeutic intervention. The rich case record will also be analysed for indirect evidence to develop a "skeptic" brief, a brief presenting an alternative explanation for the therapeutic change. Both analyses will be evaluated through a presentation of both briefs, a rebuttal of the opposing brief and a summary narrative . The adjudication process will be overseen by three independent judges who will evaluate the rich case records and briefs to provide an outcome ; whether there has been a change during the therapeutic intervention and whether the therapeutic intervention was a key influence on this outcome.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Jessica Oshodin, MSc, BSc
- 電話番号:01522 882000
- メール:29629594@students.lincoln.ac.uk
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
Woman aged 18 or over.
- Registered with a UK GP.
- Currently under the care of or recently discharged from Nottingham or Manchester Complex Mesh Centres or have contacted their GP about mesh complications.
- Has had surgery for Stress Urinary Incontinence (SUI) and/or Pelvic Organ Prolapse (POP) and has or have had implanted polypropylene mesh causing complications.
- Experiencing self-reported psychological distress.
- Able to communicate in English.
- Has access to a device with internet access.
- Willing and able to provide informed consent for participation in the study.
- Willing to engage in psychological therapy.
Exclusion Criteria:
- ACT intervention in the past twelve months due to the potential impact on the efficacy of the therapeutic intervention and to reduce cofounding variables.
- Currently engaging in psychological therapy due to the potential impact on the efficacy of the therapeutic intervention and to reduce cofounding variables.
- Have insufficient command of the English language due to resources and potential impact of an interpreter on mechanism of change.
- Significant cognitive impairment.
- Current suicidal ideation for ethical and safety reasons.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Acceptance and Commitment Therapy
Participants will receive a ten-session Acceptance and Commitment Therapy (ACT) intervention |
Acceptance and commitment therapy (ACT) is a "third wave" Cognitive Behavioural Therapy that focuses on increasing psychological flexibility and acceptance of difficult experiences by undertaking value-drive actions despite psychological suffering. Psychological flexibility is developed and expanded through six core processes: acceptance, defusion, present moment awareness, self-as-context, values and committed action. Adherence to a strict protocol is not mandated for an ACT intervention; the study will be informed by an adapted ACT intervention for chronic pain (Scott et al., 2018). The intervention will reflect the heterogenous nature of mesh injury. The intervention will consist of ten individual weekly sessions lasting up to 60 minutes. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Hermeneutic Single-Case Efficacy Design - adjudication
時間枠:Through study completion, an average of 9 months.
|
The adjudication process will be overseen by three independent judges who will evaluate the rich case records and briefs to provide an outcome ; whether there has been a change during the therapeutic intervention and whether the therapeutic intervention was a key influence on this outcome (Elliott et al., 2009). |
Through study completion, an average of 9 months.
|
|
Psychological distress assessed using the Clinical Outcomes in Route Evaluation 10 (CORE-10; Barkham et al., 2013)
時間枠:From baseline to the end of treatment, up to 16 weeks.
|
10-item measure designed to measure common presentations of psychological distress. The minimum value is 0 and the maximum value is 40. A higher score indicates severe distress. |
From baseline to the end of treatment, up to 16 weeks.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Mesh symptoms impact on quality of life assessed using the International Consultation on Incontinence Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol; Kelleher et al., 1997)
時間枠:From baseline to the end of treatment, up to 16 weeks.
|
20-item measure designed to measure the physical, emotional, social, and practical impact of urinary symptoms. Measure adapted to assess "mesh problem" instead of "urinary problem" (Brown, 2020). The minimum value is 0 and the maximum value is 76. A higher score indicates greater impact on quality of life. |
From baseline to the end of treatment, up to 16 weeks.
|
|
Psychological flexibility assessed using the Comprehensive assessment of Acceptance and Commitment Therapy Processes (CompACT-10; Golijani-Moghaddam et al., 2023)
時間枠:From baseline to the end of treatment, up to 16 weeks.
|
10-item short-form version of the Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT), designed to measure psychological flexibility and its core sub-processes. The minimum value is 0 and the maximum value is 60. A higher score indicates greater level of psychological flexibility. |
From baseline to the end of treatment, up to 16 weeks.
|
|
Therapeutic alliance assessed using the Session Rating Scale (SRS; Duncan et al., 2003)
時間枠:Weekly during the therapy intervention, up to 10 weeks.
|
4-item measure designed to measure the quality of the therapeutic alliance. The minimum value is 0 and the maximum value is 40. A higher score indicates greater therapeutic alliance. |
Weekly during the therapy intervention, up to 10 weeks.
|
|
Client's perception of therapy sessions assessed using the Helpful Aspects of Therapy (HAT; Llewelyn, 1988)
時間枠:Weekly during the therapy intervention, up to 10 weeks.
|
A measure designed to identify specific events that participants found most helpful during the therapy session. The minimum value is 1 and the maximum value is 9 for each scale. A higher score indicates greater helpful impact. |
Weekly during the therapy intervention, up to 10 weeks.
|
|
Change in client's goals assessed using the Personal Questionnaire (PQ; Elliott et al., 1999)
時間枠:Weekly during the therapy intervention, up to 10 weeks.
|
A measure personalised to the participant, identifying problems that the participant would like to work on in therapy. The minimum value is 7 and the maximum value is 91 for each scale. A higher score indicates greater progress towards goals/problem identified at the start of therapy. |
Weekly during the therapy intervention, up to 10 weeks.
|
|
Adherence to ACT processes measured using the Acceptance and Commitment Therapy Fidelity Measure (ACT-FM; O'Neill et al., 2019)
時間枠:During the therapy intervention for up to 10 weeks.
|
A measure of therapist fidelity in delivering Acceptance and Commitment Therapy. The minimum value is 0 and the maximum value is 36 for ACT consistent and ACT inconsistent subscales. A higher score for the ACT consistent subscale indicates adherence to ACT processes. |
During the therapy intervention for up to 10 weeks.
|
|
Client's perception of therapy intervention and change processes assessed using the Client Change Interview (Elliott et al., 2001)
時間枠:Within two weeks of end of therapy intervention, at 12 weeks.
|
A semi-structured interview to explore the mechanism of change. |
Within two weeks of end of therapy intervention, at 12 weeks.
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Danielle De Boos, ClinPsyD、University of Nottingham
出版物と役立つリンク
一般刊行物
- Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997 Dec;104(12):1374-9. doi: 10.1111/j.1471-0528.1997.tb11006.x.
- Llewelyn SP. Psychological therapy as viewed by clients and therapists. Br J Clin Psychol. 1988 Sep;27(3):223-37. doi: 10.1111/j.2044-8260.1988.tb00779.x.
- Scott W, Chilcot J, Guildford B, Daly-Eichenhardt A, McCracken LM. Feasibility randomized-controlled trial of online Acceptance and Commitment Therapy for patients with complex chronic pain in the United Kingdom. Eur J Pain. 2018 Apr 28. doi: 10.1002/ejp.1236. Online ahead of print.
- O'Neill, L., Latchford, G., McCracken, L. M., & Graham, C. D. (2019). The development of the Acceptance and Commitment Therapy Fidelity Measure (ACT-FM): A Delphi study and field test. Journal of Contextual Behavioral Science, 14, 111-118. https://doi.org/10.1016/j.jcbs.2019.08.008
- Elliott, R., Mack, C., & Shapiro, D. A. (1999). Simplified Personal Questionnaire procedure manual. University of Toledo, Department of Psychology, Toledo, Ohio, USA.
- Duncan, B., Miller, S., Sparks, J., Claud, D.A., Reynolds, L., Brown, J., & Johnson, LD. (2003). The Session Rating Scale: Preliminary Psychometric Properties of a "Working" Alliance Measure. Journal of Brief Therapy. 3. 3-12.
- Golijani-Moghaddam, N., Morris, J. L., Bayliss, K., & Dawson, D. L. (2023). The CompACT-10: development and validity of a comprehensive assessment of acceptance an commitment therapy processes short-form in representative UK samples. Journal of Contextual Behavioral Science, 29, 59-66. doi: 10.1016/j.jcbs.2023.06.003.
- Brown JL. The experiences of seven women living with pelvic surgical mesh complications. Int Urogynecol J. 2020 Apr;31(4):823-829. doi: 10.1007/s00192-019-04155-w. Epub 2019 Dec 4.
- Barkham, M., Bewick, B., Mullin, T., Gilbody, S., Connell, J., Cahill, J., Mellor-Clark, J., Richards, D., Unsworth, G., & Evans, C. (2013). The CORE-10: A short measure of psychological distress for routine use in the psychological therapies. Counselling & Psychotherapy Research, 13(1), 3-13. https://doi.org/10.1080/14733145.2012.729069
- Elliott R, Partyka R, Alperin R, Dobrenski R, Wagner J, Messer SB, Watson JC, Castonguay LG. An adjudicated hermeneutic single-case efficacy design study of experiential therapy for panic/phobia. Psychother Res. 2009 Jul;19(4-5):543-57. doi: 10.1080/10503300902905947.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 25010
- a85xm (レジストリ識別子:OSF)
- 363595 (その他の識別子:IRAS)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
The results of the research study will be submitted in partial fulfilment of doctoral thesis in Clinical Psychology. A journal manuscript will be submitted to a peer-reviewed journal and any data submitted will be anonymised. Any published outputs will contain a data availability statement linked to the repository. The full dataset and any special category data will not be publicly available due to participant privacy.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。